纤维蛋白质变异和低纤维蛋白质变异 - 斯洛伐克患者的致病变异谱
Dominika Jaraskova1, Jan Chandoga1, Angelika Batorova2
1Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine and University Hospital Bratislava, Comenius University, Slovakia.
概括
这项研究在斯洛伐克患有先天性低纤维素因子和缺纤维素因子症的患者中发现了纤维素因子基因 (FGA,FGB,FGG) 的六种新型遗传变异,扩大了对这些罕见出血疾病的知识.
科学领域:
- 遗传学 遗传学 是一个
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 先天性低纤维蛋白质血症 (CH) 和先天性纤维蛋白质血症 (CD) 是罕见的遗传性出血障碍.
- 这些情况是由于纤维素原基因的定量或定性缺陷造成的.
研究的目的:
- 研究先天性纤维素原体疾病的遗传基础和临床特征.
- 专注于斯洛伐克在国家血友病中心注册的患者.
主要方法:
- 进行了纤维素基因 (FGA,FGB,FGG) 的遗传分析.
- 使用聚合酶链反应 (PCR),然后进行直接测序.
- 分析了36名患有先天性纤维激素疾病的患者.
主要成果:
- 在FGA,FGB和FGG基因中发现了6种新的遗传变异.
- 在CD (FGA,FGG) 和CH (FGG,FGB) 患者中发现了特定的变异.
- 详细的分子遗传发现报告了每个已识别的变种.
结论:
- 这项研究有助于了解先天性纤维素原体疾病中的遗传变异.
- 鉴定出的新型变异扩大了已知的遗传缺陷的范围.
- 提供了关于斯洛伐克人口中这些疾病的遗传情景的宝贵数据.
相关概念视频
Disorders of Hemostasis
758
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
758
Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K


